SEMI-FINALISTS announced

Health Industry Hub Catalysts for Change Awards 2023

We are thrilled to announce the SEMI-FINALISTS for the Health Industry Hub Catalysts for Change Awards, as we approach the much-anticipated FINALISTS revelation on September 19th. The pinnacle of this journey will be the ceremony on November 1st, where the WINNERS will crowned.

The Awards recognise and celebrate the MOST VIEWED vodcasts and TOP podcasts featuring leaders and change-makers who have captivated our audience across the healthcare sector, including the pharma, medtech, diagnostics and biotech industries. These remarkable individuals and organisations that inspire us to challenge the status quo and embark on a purposeful journey to reimagine healthcare.

SEMI-FINALISTS

At Health Industry Hub, we believe in the power of collective engagement and the strength of our diverse audience. That’s why we are thrilled that once again YOU, our incredible Health Industry Hub audience from the pharma, medtech, diagnostics and biotech sectors, are serving as the esteemed judges for the prestigious Catalysts for Change Awards 2023. Your active participation across all our digital and social media channels is shaping the destiny of these Awards as we analyse the overall engagement data.

A huge congratulations to all the SEMI-FINALISTS (in alphabetical order)

AbbVie
Amgen
AstraZeneca
Australian Diabetes Society (ADS)
Australian Private Hospitals Association (APHA)
Bayer
BeiGene
Bristol Myers Squibb (BMS)
Boehringer Ingelheim
Edwards Lifesciences
Gilead
hearts4heart
Johnson & Johnson MedTech
Janssen
Lung Foundation
Medical Affairs Professionals of Australasia (MAPA)
Medicines Australia
Medtronic
Merck
Medical Technology Association of Australia (MTAA)
National Youth Science Forum (NYSF)
Novartis
Noxopharm
Organon
PAIG (Pharma Australia Inclusion Group)
Patient Voice Initiative
Pen CS
Pfizer
Philips
Pink Hope
Prostate Cancer Foundation of Australia (PCFA)
Queensland University of Technology (QUT)
Roche Diagnostics
Sanofi
Stryker
Varian
Viatris

Event Information

Date: Wednesday, 1st November 2023
Time: 6pm – 9:30pm
Venue: Dockside, The Balcony Level, Cockle Bay Wharf, Darling Harbour
Tickets: Book your tickets here!

Add to Calendar

Office 365  •  Outlook Web  •  Outlook  •  Google • Apple    

Important Dates

  • Finalists to be announced on 19 September 2023
  • Live Event and winners crowned on 1 November 2023

2022 Winners

Cardinal Health, Merck Healthcare, Patient Voice Initiative, Gilead Sciences, Bristol Myers Squibb, Johnson & Johnson MedTech, Pfizer, Medtronic, AbbVie, Sanofi, Viatris, hearts4heart, Medical Affairs Professionals of Australasia, Research Australia, Paras and Partners and Hunton Executive More…

Mark your calendars for September 19th as we reveal the FINALISTS!

GOLD SPONSORS

News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.